UCB gets access to rights for an antibody program from WILEX for non-oncology indications
WILEX will be reimbursed an undisclosed amount for its development costs to date and shall be eligible for future, undisclosed ...
WILEX will be reimbursed an undisclosed amount for its development costs to date and shall be eligible for future, undisclosed ...
FasterCapital has added a rice production and processing startup to EquityPilot, the firm’s execution-focused program designed to help early-stage ventures...
Read moreDetails
PressCenter.com is state-of-the-art Press Release Distribution Platform. PressCenter.com send and track your Press Release using our industry-leading global Media Contacts Database of a million contacts. Your Press Release will reach business news editors and journalists, in targeted sectors and territories or worldwide.
© 1998-2025 PressCenter.com - Latest Business News and Press Releases
© 1998-2025 PressCenter.com - Latest Business News and Press Releases